Regeneron reaches deal with Trump administration to lower drug prices and avoid planned tariffs. CEO Leonard Schleifer says the company aims to balance industry support with drug affordability.
Regeneron has reached an agreement with the Trump administration to reduce drug prices in exchange for avoiding planned tariffs. CEO Leonard Schleifer stated the company aims to support the industry while ensuring drug affordability.
What happened
Regeneron has reached an agreement with the Trump administration to reduce drug prices in exchange for avoiding planned tariffs. CEO Leonard Schleifer stated the company aims to support the industry while ensuring drug affordability.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near United States
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
US consumer sentiment drops to record low in April as economic concerns over Iran war intensify. The decline reflects growing anxiety among households regarding the broader financial fallout from the ongoing conflict.
US consumer sentiment declined in April to a record low, with reports citing concerns over the economic impact of the war involving Iran.
Shipping firms pay up to $4 million for Panama Canal transit slots amid ongoing disruptions in the Strait of Hormuz. The surge in costs reflects broader volatility in global maritime logistics.
Businesses are paying up to $4 million in fees to secure transit through the Panama Canal as global shipping routes face disruptions linked to the Strait of Hormuz.
White House expresses confidence in swift Senate confirmation of Kevin Warsh as next Federal Reserve Chairman.
The White House expressed confidence that the Senate will move quickly to confirm Kevin Warsh as the next Chairman of the Federal Reserve.
UPDATE: The Trump administration maintains confidence in U.S. munitions stockpiles after over a month of conflict with Iran, despite ongoing questions regarding long-term supply chain sustainability.
The Trump administration is expressing confidence in U.S. military munitions reserves following more than a month of conflict with Iran, though concerns regarding long-term supply sustainability persist.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.